New Products In Brief
This article was originally published in The Rose Sheet
Executive Summary
Transdel: La Jolla, Calif.-based pharmaceutical company developing non-invasive, topically administered medications says it may be able to generate revenue this year by expanding its development program to include cosmetics/cosmeceuticals. Products would feature the same patented Transdel transdermal delivery system used in the start-up's lead product - Ketotransdel, a topical cream-based non-steroidal anti-inflammatory drug - which currently is in Phase III trials for acute pain. Transdel says it has initiated discussions with potential sales and marketing partners for specific cosmetic products